全文获取类型
| 收费全文 | 2945篇 |
| 免费 | 78篇 |
| 国内免费 | 3篇 |
专业分类
| 耳鼻咽喉 | 3篇 |
| 儿科学 | 102篇 |
| 妇产科学 | 36篇 |
| 基础医学 | 81篇 |
| 口腔科学 | 66篇 |
| 临床医学 | 108篇 |
| 内科学 | 329篇 |
| 皮肤病学 | 14篇 |
| 神经病学 | 35篇 |
| 特种医学 | 144篇 |
| 外科学 | 111篇 |
| 综合类 | 13篇 |
| 预防医学 | 1873篇 |
| 眼科学 | 8篇 |
| 药学 | 16篇 |
| 肿瘤学 | 87篇 |
出版年
| 2024年 | 7篇 |
| 2023年 | 31篇 |
| 2022年 | 51篇 |
| 2021年 | 31篇 |
| 2020年 | 89篇 |
| 2019年 | 25篇 |
| 2018年 | 92篇 |
| 2017年 | 98篇 |
| 2016年 | 98篇 |
| 2015年 | 90篇 |
| 2014年 | 87篇 |
| 2013年 | 160篇 |
| 2012年 | 27篇 |
| 2011年 | 30篇 |
| 2010年 | 109篇 |
| 2009年 | 127篇 |
| 2008年 | 58篇 |
| 2007年 | 66篇 |
| 2006年 | 75篇 |
| 2005年 | 51篇 |
| 2004年 | 44篇 |
| 2003年 | 25篇 |
| 2002年 | 84篇 |
| 2001年 | 90篇 |
| 2000年 | 54篇 |
| 1999年 | 134篇 |
| 1998年 | 157篇 |
| 1997年 | 194篇 |
| 1996年 | 206篇 |
| 1995年 | 129篇 |
| 1994年 | 55篇 |
| 1993年 | 121篇 |
| 1992年 | 19篇 |
| 1991年 | 11篇 |
| 1990年 | 15篇 |
| 1989年 | 32篇 |
| 1988年 | 31篇 |
| 1987年 | 23篇 |
| 1986年 | 29篇 |
| 1985年 | 21篇 |
| 1984年 | 11篇 |
| 1983年 | 16篇 |
| 1982年 | 15篇 |
| 1981年 | 15篇 |
| 1980年 | 11篇 |
| 1979年 | 9篇 |
| 1978年 | 8篇 |
| 1977年 | 9篇 |
| 1976年 | 17篇 |
| 1975年 | 7篇 |
排序方式： 共有3026条查询结果，搜索用时 15 毫秒
31.
32.
33.
34.
Redvanly RD; Chezmar JL; Strauss RM; Galloway JR; Boyer TD; Bernardino ME 《Radiology》1993,188(1):283
35.
RD Vaithilingam SH Safii NA Baharuddin LP Karen‐Ng R Saub F Ariffin H Ramli A Sharifuddin MFH Hidayat R Raman YK Chan NA Rani RA Rahim N Shahruddin SC Cheong PM Bartold RB Zain 《Oral diseases》2015,21(1):e62-e69
Periodontal bio‐repositories, which allow banking of clinically validated human data and biological samples, provide an opportunity to derive biomarkers for periodontal diagnosis, prognosis and therapeutic activities which are expected to improve patient management. This article presents the establishing of the Malaysian Periodontal Database and Biobank System (MPDBS) which was initiated in 2011 with the aim to facilitate periodontal research. Partnerships were established with collaborating centres. Policies on specimen access, authorship and acknowledgement policies were agreed upon by all participating centres before the initiation of the periodontal biobank. Ethical approval for the collection of samples and data were obtained from institutional ethics review boards. A broad‐based approach for informed consent was used, which covered areas related to quality of life impacts, genetics and molecular aspects of periodontal disease. Sample collection and processing was performed using a standardized protocol. Biobanking resources such as equipment and freezers were shared with the Malaysian Oral Cancer Database and Tissue Bank System (MOCDTBS). In the development of the MPDBS, challenges that were previously faced by the MOCDTBS were considered. Future challenges in terms of ethical and legal issues will be faced when international collaborations necessitate the transportation of specimens across borders. 相似文献
36.
37.
Parathyroid adenomas evaluated by Tl-201/Tc-99m pertechnetate subtraction scintigraphy and high-resolution ultrasonography 总被引：2，自引：0，他引：2
Winzelberg GG; Hydovitz JD; O'Hara KR; Anderson KM; Turbiner E; Danowski TS; Lippe RD; Melada GA; Harrison AM 《Radiology》1985,155(1):231-235
Thallium-201/technetium-99m pertechnetate subtraction scintigraphy of the parathyroid glands was performed in a prospective study of 33 patients who had undergone bilateral neck exploration for elevated serum calcium and serum parathyroid hormone levels. In 31 cases, the Tl-201/Tc-99m subtraction technique yielded an overall sensitivity of 81%, specificity of 99%, and accuracy of 94% for identifying solitary parathyroid adenomas. Tl-201/Tc-99m subtraction scintigraphy correctly identified 73% of parathyroid adenomas weighing less than 499 mg, 79% of those weighing 500-1,499 mg, and 100% of adenomas weighing more than 1,500 mg. In a subgroup of 24 patients with solitary parathyroid adenomas who underwent both scintigraphy and high-resolution sonography, the sensitivity, specificity, and accuracy of both procedures were similar. 相似文献
38.
39.
40.
Mercher T Wernig G Moore SA Levine RL Gu TL Fröhling S Cullen D Polakiewicz RD Bernard OA Boggon TJ Lee BH Gilliland DG 《Blood》2006,108(8):2770-2779
Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia associated with a poor prognosis. However, there are relatively few insights into the genetic etiology of AMKL. We developed a screening assay for mutations that cause AMKL, based on the hypothesis that constitutive activation of STAT5 would be a biochemical indicator of mutation in an upstream effector tyrosine kinase. We screened human AMKL cell lines for constitutive STAT5 activation, and then used an approach combining mass spectrometry identification of tyrosine phosphorylated proteins and growth inhibition in the presence of selective small molecule tyrosine kinase inhibitors that would inform DNA sequence analysis of candidate tyrosine kinases. Using this strategy, we identified a new JAK2T875N mutation in the AMKL cell line CHRF-288-11. JAK2T875N is a constitutively activated tyrosine kinase that activates downstream effectors including STAT5 in hematopoietic cells in vitro. In a murine transplant model, JAK2T875N induced a myeloproliferative disease characterized by features of AMKL, including megakaryocytic hyperplasia in the spleen; impaired megakaryocyte polyploidization; and increased reticulin fibrosis of the bone marrow and spleen. These findings provide new insights into pathways and therapeutic targets that contribute to the pathogenesis of AMKL. 相似文献